Impact News +++ DAX vor Abverkauf? – Allianz, Bechtle, Hensoldt, Nagarro, Siemens Energy, SMA Solar im Check (Der Aktionaer) +++ SMA SOLAR Aktie -4,49%

CO-DIAGNOSTICS Aktie

>CO-DIAGNOSTICS Aktienkurs

0.284 EUR -11.8% (Tradegate)

Ask: 0.312 EUR / 5000 Stück

Bid: 0.284 EUR / 5000 Stück

Tagesumsatz: 13680 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>CO-DIAGNOSTICS Performance

1 Woche: -1,8%

1 Monat: +3,8%

3 Monate: +49,5%

6 Monate: -2,4%

1 Jahr: -69,2%

laufendes Jahr: -52,8%

>CO-DIAGNOSTICS Aktie

Name:

CO-DIAGNOSTICS DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1897631057 / A2DU6V

Symbol/ Ticker:

C97 (Frankfurt) / CODX (NASDAQ)

Kürzel:

FRA:C97, ETR:C97, C97:GR, NASDAQ:CODX

Index:

Webseite:

https://codiagnostics.com..

Profil:

Co-Diagnostics Inc. is a molecular diagnostics com..
>Volltext..

Marktkapitalisierung:

20.48 Mio. EUR

Unternehmenswert:

10.62 Mio. EUR

Umsatz:

0.49 Mio. EUR

EBITDA:

-32.57 Mio. EUR

Nettogewinn:

-30.93 Mio. EUR

Gewinn je Aktie:

-0.96 EUR

Schulden:

1.46 Mio. EUR

Liquide Mittel:

9.55 Mio. EUR

Operativer Cashflow:

-27.92 Mio. EUR

Bargeldquote:

3.6

Umsatzwachstum:

-91.94%

Gewinnwachstum:

12.89%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

CO-DIAGNOSTICS, CO DIAGNOSTICS

Letzte Datenerhebung:

14.11.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 60.14 Mio. St.

Frei handelbar: 91.48%

Leerverk. Aktien: 5.01%

Rückkaufquote: -3.73%

Mitarbeiter: 132

Umsatz/Mitarb.: 0.01 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 587.98%

Bewertung:

KGV: -

KGV lG: -

KUV: 25.61

KBV: 0.38

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -231.3%

Gewinnmarge: -6321%

Operative Marge: -6882.12%

Managementeffizenz:

Gesamtkaprendite: -56.6%

Eigenkaprendite: -63.4%

>Peer Group

Es sind 599 Aktien bekannt.

>CO-DIAGNOSTICS Chart & Kurs - NASDAQ

>CO-DIAGNOSTICS News

14.11.25 - 01:00	Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
	CoDiagnostics (CODX) delivered earnings and revenue surprises of +15.79% and -51.67%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...

14.11.25 - 00:00	Co-Diagnostics (CODX) Q3 2025 Earnings Transcript (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

13.11.25 - 22:03	Co-Diagnostics Reports Third Quarter 2025 Financial Results (PR Newswire)
	SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced its financial results for......

12.11.25 - 17:18	Co-Diagnostics Q3 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.25 - 14:03	Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast (PR Newswire)
	SALT LAKE CITY, Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2025 financial results on Thursday,......

30.10.25 - 19:00	Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia (PR Newswire)
	SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host a virtual fireside chat on......

29.10.25 - 17:57	Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire)
	SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced......

28.10.25 - 20:12	Co-Diagnostics: Aktie stürzt nach Ankündigung einer 7-Millionen-Dollar-Kapitalerhöhung ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

28.10.25 - 14:36	Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire)
	SALT LAKE CITY, Oct. 28, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase......

27.10.25 - 18:54	Co-Diagnostics Stock Is Rocketing Higher Monday: What′s Going On? (Benzinga)
	Co-Diagnostics shares are trading higher Monday after the company signed a definitive agreement to establish CoMira Diagnostics. read more...

27.10.25 - 14:48	Aktie von Co-Diagnostics verdoppelt sich nach Joint-Venture-Ankündigung in Saudi-Arabien (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 14:15	EXCLUSIVE: Co-Diagnostics Inks JV With Saudi Arabia Firm For Middle East Market (Benzinga)
	Co-Diagnostics (Nasdaq: CODX) entered a joint venture with Arabian Eagle Manufacturing to develop and commercialize Co-Dx technologies in Saudi Arabia and other Middle East and North Africa countries. read more...

27.10.25 - 13:48	Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East (PR Newswire)
	The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries SALT LAKE CITY, Oct. 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX)......

16.10.25 - 15:33	Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing (PR Newswire)
	New device has the potential to help empower decentralized PCR testing in nearly 30,000 primary health centers across India, advancing efforts to improve availability of life-saving TB diagnostics SALT LAKE CITY, Oct. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the......

13.10.25 - 15:33	Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit (PR Newswire)
	SALT LAKE CITY, Oct. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today its participation in the upcoming 2025 Maxim......

30.09.25 - 15:33	Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30 (PR Newswire)
	SALT LAKE CITY, Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in a webcast......

18.09.25 - 23:06	Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire)
	SALT LAKE CITY, Sept. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced......

17.09.25 - 15:48	Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire)
	SALT LAKE CITY, Sept. 17, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has entered into a securities purchase......

17.09.25 - 12:06	Co-Diagnostics Stock Plunges 28% In Pre-Market Despite Strategic Saudi Partnership (Benzinga)
	Co-Diagnostics (CODX) shares dropped 24.87% in pre-market trading after an 80.76% surge, despite announcing a strategic partnership. read more...

16.09.25 - 15:33	Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East (PR Newswire)
	The Memorandum of Understanding includes the formation of a Joint Venture in the Kingdom of Saudi Arabia for manufacturing and distribution of the Company's upcoming Co-Dx™ PCR platform and other Co-Dx IP SALT LAKE CITY, Sept. 16, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX)......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wie der Pfaff, so die Gemeinde. - Sprichwort Rußland

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram